Shanghai Henlius Biotech has resubmitted its application to list on the Hong Kong Stock Exchange with an IPO worth around $500m. The biotechnology company is being spun off by parent Shanghai Fosun …
( read original story …)
The Shanghai News
Shanghai Henlius Biotech has resubmitted its application to list on the Hong Kong Stock Exchange with an IPO worth around $500m. The biotechnology company is being spun off by parent Shanghai Fosun …
( read original story …)